All lobbying filings
Thorn Run Partners
Thorn Run Partners filed a Q4 report for Otsuka America Pharmaceutical, Inc. on January 20, 2026, reporting $50,000 in lobbying income.
Lobbying for Otsuka America Pharmaceutical, Inc. · Pharmaceutical manufacturer.
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Maryland
Lobbyists on this filing
1
-
BEAU SCHUYLERPreviously held: Legislative Director, Rep. Tanner; Legislative Director, Rep. McIntyre
Government bodies contacted
2
Lobbying activity
3
Pharmaceutical reimbursement issues.
Issues related to neurological treatments.
Corporate tax issues.